Description
The GI-MAP (Gastrointestinal Microbial Assay Plus) is a comprehensive, DNA-based stool test that uses quantitative polymerase chain reaction (qPCR) technology to detect and measure a wide range of microbes in the gut, including bacteria, parasites, fungi, and viruses.
Unlike other stool tests, GI-MAP provides precise quantitative data that allows clinicians to assess the clinical relevance of microbial imbalances and pathogenic infections with accuracy, sensitivity, and reproducibility.
This advanced technology is trusted in clinical research and surpasses traditional methods like culture, microscopy, and standard PCR in both reliability and clinical insight. The GI-MAP also includes markers of gut health and intestinal permeability—such as Zonulin—which helps assess the integrity of the gut barrier.
With its highly specific results, the GI-MAP allows for personalized treatment plans and effective tracking of patient progress through retesting.
The StoolOMX™ add-on further enhances the GI-MAP by analyzing:
- 25 bile acids (total, percentage, and ratio)
- 9 short chain fatty acids (SCFAs)
These markers provide critical insight into fat digestion, gut motility, inflammation, microbiome function, and metabolic health. Bile acid imbalances and SCFA disruptions are often linked to conditions such as IBS, IBD, bile acid diarrhea, and gut dysbiosis.
By combining GI-MAP with Zonulin & StoolOMX, practitioners can uncover deeper insights into:
- Gut microbiota composition and function
- Gut lining integrity and inflammation
- Bile acid metabolism and fat absorption
- SCFA production from dietary fiber fermentation
- Root causes of symptoms like bloating, constipation, diarrhea, and fatigue
Who Can Benefit?
This test is valuable for:
- Chronically ill patients with undiagnosed conditions
- Individuals seeking optimal health
- Patients with digestive issues, autoimmune disease, mood disorders, or skin problems
- Children with behavioral concerns (e.g., ADHD, Autism) or GI symptoms
